JLHL · Healthcare · Medical Care Facilities
Composite scorecard: 37/100 — Quality 57 · Valuation 16 · Momentum 28
| Share price | ₹1,558.10 |
| Market cap | ₹9,545 Cr |
| P/E ratio | 49.3 |
| P/B ratio | 6.2 |
| ROE | 24.2% |
| ROCE | 13.3% |
| Dividend yield | 0.07% |
| Book value | ₹235.50 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,500 Cr | ₹194 Cr | 23.0% |
| 2025 | ₹1,302 Cr | ₹194 Cr | 23.0% |
| 2024 | ₹1,073 Cr | ₹177 Cr | 23.0% |
| 2023 | ₹893 Cr | ₹73 Cr | 23.0% |
| 2022 | ₹733 Cr | ₹51 Cr | 21.0% |
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, on